Carboxy Therapy

CARBOXITHERAPY

It is a non surgical method which consists of injecting CO2 at subcutaneous level through a very fine needle (3mm) by using an equipment especially designed for regulating the gas exit with a low pressure.

What is it?

Characteristics of CO2

Non scent, colorless, soluble in water

Final product of the organic metabolism

High disolution ( 20 times more than O2 in the microcirculation)

Modest transformation in HCO3

Origen of Carboxitherapy

1930 : France . Gas de Royat. Arteriopaties

1930 : Argentine Medical Association

1953: Publication of 20 experienced years with subcutaneous injections

Action mecanisms. Active Vaso-dilatation Increment of oxidatve phenomena Arteriolization of blood (Bohr

effect) Increasing of cellular oxygenation Lipolitic effect Sympatic-litic effect

Toxicity Absence of toxicity with high dose Absence of increment in the

systemic TA No variations in the systemic

partial pressure of O2 and CO2

Medical directions

Angiology: Arteriopaties, microangiopaties

Reumatology: Arthritis Urology: Erectil disfunction by

angiopaties Dermatology: Psoriasis, ulcers

related to microangiopaties.

Therapeutic directions

Vascular and artery pathologies Acute arthritis Sports Medicine Healing defects

Aesthetic indications

Cellulitis Located adiposity Pre liposculpture Pos lipoescuplture

Contraindications IAM, unstable anginas ICC HTA Acute tromboflebitis Located Infections Epilepsy Pregnancy Renal and respiratory insufficiencies

Treatment sessions

Between 15 and 20 sessions of approximately 10 minutes each, are suggested according to the different cases. The intensity per week is 2 or 3.

Treatment protocol

1. The suggested dose of CO2 per member should oscillate between 100 and 200 cc.

2. Divide the treated zone into 4 or 6 quadrants in eah member. It is suggested not to inject more than 30 o 50 cc per zone.

3. It is convenient to jab in several directions.

4. Injections should be complemented with manual massages to spread the gas, control the efisema and dicrease the annoyance on the patient

Clinic cases

Patient with multiple symmetrical lipomatosis; pre-surgery situation

(frontal)

Patient with multiple symmetrical lipomatosis; pre-surgery situation

(lateral)

. Patient with multiple symmetrical lipomatosis; pos-surgery situation

(frontal)

Patent with multiple symmetrical lipomatosis; pos surgery situation

(lateral)

Clinic cases

Microphotograph

Figure1. Microphotograph of the abdominal subcutaneous weave

on the patient with multiple symmetrical lipomatosis : biopsy before the treatment with CO2

Figure 2. Microphotography of the abdominal subcutaneous weave on the

patient with multiple symmetrical lipomatosis : biopsy after the treatment

with CO2. The areas of lisis adipocitaries are evident, with

conservation of the anatomic integrity of the vascular system.

Bibliography1. Hartmann B.R., Bassenge E., Pittler M.: «Effect of carbon

dioxide enriched water on the cutaneous mícrocirculation and oxygen tension in the skin of the foot». Angiology, 48, 957, 1997.

2. Klopstock T., Naumann M., Seibel P., et al.: «Mitocondrial DNA mutations in multiple Symmetric lipomatosis». Mol. Cell. Biochem., 17, 271, 1997.

3. Savin E., Bailliart O., Bonnin P., et al.: «Vasomotor effects of transcutaneous CO2 in stage. Il peripheral occlusive arterial disease». Angiology, 46, 785, 1995.

4. Smith P.D., Stadelmann W.K., Wassemann R.J., et al.: «Benign symmetric lipomatosis (Madelung's disease)». Ann. Plast. Surg., 41, 671, 1998.

Stavropoulos P.G., Wouboulis C.C., Trautmann C., et al.: «Symmetric lipomatoses in female patients». Dermatology, 194, 26, 1997.

THANKS FOR YOUR ATENTION